Assessment of Response of Patients on Surveillance for Favorable Risk Prostate Cancer to Dutasteride

Trial Profile

Assessment of Response of Patients on Surveillance for Favorable Risk Prostate Cancer to Dutasteride

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2015

At a glance

  • Drugs Dutasteride (Primary)
  • Indications Prostate cancer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 09 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top